本文選題：宮內(nèi)合并宮外妊娠 + 選擇性減胎　； 參考：《中國實(shí)用婦科與產(chǎn)科雜志》2017年03期

【摘要】：正體外受精-胚胎移植(IVF-ET)術(shù)后宮內(nèi)合并宮外妊娠(heterotopy pregnancy,HP)是指2個或多個胚胎在生殖系內(nèi)的不同部位同時發(fā)育,其中至少1個屬于宮內(nèi)正常妊娠,其余為異位妊娠(EP)[1]。隨著輔助生殖技術(shù)(ART)的廣泛應(yīng)用,門診促排卵、人工授精、IVF-ET的患者增加,HP的發(fā)病率越來越高。1989年美國生殖協(xié)會首先報(bào)告IVF-ET術(shù)后宮內(nèi)合并宮外妊娠的發(fā)病率為
[Abstract]:In vitro fertilization-embryo transfer (IVF-ETT) after intrauterine pregnancy with heterotopy pregnancyne (HPP) means that two or more embryos develop simultaneously in different parts of the reproductive system, at least one of them belongs to normal intrauterine pregnancy and the other to ectopic pregnancy (EP1) [1]. With the wide use of assisted reproductive technology (ART), the incidence of HP increased in patients with IVF-ET and IVF-ET. In 1989, the American Reproductive Association first reported that the incidence of intrauterine pregnancy with extrauterine pregnancy after IVF-ET was as follows:
【作者單位】： 沈陽市婦嬰醫(yī)院生殖中心;
【分類號】：R711.71
，

本文編號：2032872